Piramal Pharma is seeing strong momentum in CDMO. Buy for TP ₹320 (27% upside)

Discussion in 'Latest Brokerage Stock Buy-Sell Reports' started by Vidhi Khanna, Dec 25, 2024 at 9:09 PM.

  1. Vidhi Khanna

    Vidhi Khanna Active Member Staff Member

    Joined:
    Mar 19, 2015
    Messages:
    761
    Likes Received:
    55
    Piramal Pharma is seeing strong momentum in CDMO. Postponement of the Biosecure Act is unlikely to cause growth related issues as China rebalancing drive by global innovators likely to continue. Other growth levers are intact. Buy for TP ₹320 (27% upside)

    Download report

    [​IMG]
     
Loading...